SEC Form 4 · accession 0001193125-26-268109
Mobia Medical, Inc. · MOBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nelson Bunker Curnes
Officer — Chief Financial Officer
Period of report
Feb 23, 2026
Accepted (ET)
Jun 11, 2026 · 7:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001489993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2026 | J | 249,750 | $0.00 | D | 560,068 | I | By Exceller Hunt Microtransponder 2017, LP |
| Common StockF1 | Feb 23, 2026 | J | 175,077 | $0.00 | D | 0 | I | By Curnes Fund 2001 |
| Common StockF3,F4 | Jun 9, 2026 | P | 5,000 | $12.7938 | A | 366,997 | D | |
| Common Stock | holding | — | — | — | 5,742 | I | By Family Trusts |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).
- F2Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.
- F3The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
- F4Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13.